IIT Madras Study Finds Inherited Cancer-Risk Variants

IIT Madras Study Finds Inherited Cancer-Risk Variants

A study by IIT Madras, Kumaran Hospital and Chennai Breast Centre analysed germline DNA from 479 breast-cancer patients in India. Published in BMC Cancer, it found that 24.6% had at least one pathogenic or likely pathogenic inherited variant linked to cancer risk.

Findings beyond BRCA genes

Many identified variants were outside BRCA1 and BRCA2. The researchers also reported clinically significant secondary genetic findings in 21% of participants, including risks associated with Marfan syndrome, hereditary cardiac rhythm disorders and hereditary cholesterol disorders. The study is part of the Bharat Cancer Genome Atlas, an open-access cancer genomics data resource. Professor S. Mahalingam of IIT Madras said the findings could inform clinical practice, public health policy and national cancer guidelines.

Pharmacogenomic findings

The study highlighted pharmacogenomics—the influence of genetic variation on responses to medicines. It identified DPYD gene variations in Indian patients that can cause severe toxicity with certain drugs, including 5-fluorouracil (5-FU) and capecitabine. First author Dr John Peter noted that the research also found secondary health risks beyond cancer.

Important Facts for Exams

  • Genetic scope: Pharmacogenomics covers polygenic drug-response traits and can include transcriptomic, proteomic and metabolomic data; pharmacogenetics focuses on single-gene–drug interactions.
  • Germline–somatic distinction: Germline variants are present in constitutional cells, unlike tumour-acquired somatic variants; they may also be transmitted to biological offspring.
  • Secondary versus incidental findings: A secondary finding is a medically relevant result sought outside the primary test indication, unlike an incidental finding discovered unexpectedly during analysis.
  • DPYD enzyme mechanism: DPYD encodes dihydropyrimidine dehydrogenase, the principal enzyme initiating fluoropyrimidine breakdown; reduced activity can increase drug exposure and treatment toxicity.
Category: Tamil Nadu
Originally written on March 2, 2026 and last modified on November 19, 2026.
Tags: , , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *